Paternal nicotine enhances fear memory, reduces nicotine administration, and alters hippocampal genetic and neural function in offspring.
cholinergic
hippocampus
learning
multigenerational
nicotine
transgenerational
Journal
Addiction biology
ISSN: 1369-1600
Titre abrégé: Addict Biol
Pays: United States
ID NLM: 9604935
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
08
07
2019
revised:
07
10
2019
accepted:
07
11
2019
pubmed:
30
11
2019
medline:
10
9
2021
entrez:
30
11
2019
Statut:
ppublish
Résumé
Nicotine use remains highly prevalent with tobacco and e-cigarette products consumed worldwide. However, increasing evidence of transgenerational epigenetic inheritance suggests that nicotine use may alter behavior and neurobiology in subsequent generations. We tested the effects of chronic paternal nicotine exposure in C57BL6/J mice on fear conditioning in F1 and F2 offspring, as well as conditioned fear extinction and spontaneous recovery, nicotine self-administration, hippocampal cholinergic functioning, RNA expression, and DNA methylation in F1 offspring. Paternal nicotine exposure was associated with enhanced contextual and cued fear conditioning and spontaneous recovery of extinguished fear memories. Further, nicotine reinforcement was reduced in nicotine-sired mice, as assessed in a self-administration paradigm. These behavioral phenotypes were coupled with altered response to nicotine, upregulated hippocampal nicotinic acetylcholine receptor binding, reduced evoked hippocampal cholinergic currents, and altered methylation and expression of hippocampal genes related to neural development and plasticity. Gene expression analysis suggests multigenerational effects on broader gene networks potentially involved in neuroplasticity and mental disorders. The changes in fear conditioning similarly suggest phenotypes analogous to anxiety disorders similar to post-traumatic stress.
Identifiants
pubmed: 31782218
doi: 10.1111/adb.12859
pmc: PMC8442877
mid: NIHMS1738143
doi:
Substances chimiques
Nicotine
6M3C89ZY6R
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12859Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR002245
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA041632
Pays : United States
Organisme : NIDA NIH HHS
ID : 1U01DA041632
Pays : United States
Organisme : NIDA NIH HHS
ID : R03 DA037421
Pays : United States
Organisme : NIDA NIH HHS
ID : DA017949
Pays : United States
Organisme : NIDA NIH HHS
ID : DA037421
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA017949
Pays : United States
Organisme : NIDA NIH HHS
ID : DP1 DA039658
Pays : United States
Informations de copyright
© 2019 Society for the Study of Addiction.
Références
Methods Mol Biol. 2018;1708:383-405
pubmed: 29224155
Behav Neurosci. 1997 Feb;111(1):104-13
pubmed: 9109628
Behav Neurosci. 2004 Feb;118(1):97-110
pubmed: 14979786
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Curr Drug Abuse Rev. 2008 Jan;1(1):9-19
pubmed: 19630701
Science. 1983 Apr 8;220(4593):214-6
pubmed: 6828889
Eur J Neurosci. 2019 Aug;50(3):2453-2466
pubmed: 29949212
Sci Rep. 2017 Aug 4;7(1):7286
pubmed: 28779169
J Neurochem. 2010 Nov;115(3):625-34
pubmed: 20796176
J Neurosci. 2014 Feb 19;34(8):2768-73
pubmed: 24553919
Behav Brain Res. 2014 Apr 15;263:133-7
pubmed: 24487010
Nat Neurosci. 2016 Jul;19(7):905-14
pubmed: 27239938
Dis Markers. 2011;30(2-3):101-10
pubmed: 21508514
JAMA. 2000 Nov 8;284(18):2348-51
pubmed: 11066185
Nature. 2011 Mar 31;471(7340):597-601
pubmed: 21278726
Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):32-6
pubmed: 24420984
Nat Biotechnol. 2010 May;28(5):511-5
pubmed: 20436464
Psychopharmacology (Berl). 2013 Jan;225(1):201-8
pubmed: 22836371
Epigenetics. 2011 Jul;6(7):838-42
pubmed: 21637037
Neuron. 2010 Jan 14;65(1):7-19
pubmed: 20152109
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Nucleic Acids Res. 2016 Jul 8;44(W1):W3-W10
pubmed: 27137889
J Neurosci. 2005 Sep 21;25(38):8708-13
pubmed: 16177040
J Neurosci. 1990 Apr;10(4):1062-9
pubmed: 2329367
J Pharmacol Exp Ther. 2003 Nov;307(2):526-34
pubmed: 12970387
Brain Res Bull. 2018 Apr;138:50-55
pubmed: 28624583
J Neurosci. 2010 Mar 3;30(9):3518-30
pubmed: 20203212
Addict Biol. 2020 Mar;25(2):e12730
pubmed: 30950138
Int Rev Neurobiol. 2015;124:171-208
pubmed: 26472530
Neurobiol Learn Mem. 2018 Nov;155:239-248
pubmed: 30099202
Biol Psychiatry. 2009 Dec 15;66(12):1075-82
pubmed: 19748076
Behav Brain Res. 2001 Nov 1;125(1-2):279-84
pubmed: 11682119
Hippocampus. 2012 Aug;22(8):1681-90
pubmed: 22271264
Neuropharmacology. 2011 Sep;61(4):687-98
pubmed: 21640128
Eur J Neurosci. 2016 Nov;44(10):2818-2828
pubmed: 27623427
Drug Metab Dispos. 1984 Nov-Dec;12(6):725-31
pubmed: 6150822
Genome Biol. 2012 Oct 03;13(10):R87
pubmed: 23034086
Neurobiol Learn Mem. 2019 May;161:63-71
pubmed: 30898692
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Behav Neurosci. 2003 Dec;117(6):1276-82
pubmed: 14674846
Int J Neuropsychopharmacol. 2008 May;11(3):419-24
pubmed: 18190729
Mol Brain. 2019 Mar 28;12(1):25
pubmed: 30922409
Neuropharmacology. 2012 Apr;62(5-6):2118-25
pubmed: 22285742
Prev Chronic Dis. 2016 Aug 04;13:E103
pubmed: 27490368
Psychopharmacology (Berl). 2006 Mar;184(3-4):345-52
pubmed: 15988571
Neuropsychopharmacology. 2014 Nov;39(12):2777-87
pubmed: 24889368
Biol Psychiatry. 2009 Oct 1;66(7):708-11
pubmed: 19393990
Front Psychiatry. 2013 Sep 27;4:118
pubmed: 24098286
Behav Brain Res. 1999 Jul;102(1-2):31-9
pubmed: 10403013
Neuropharmacology. 2016 Oct;109:341-348
pubmed: 27378334
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Behav Brain Res. 2001 Nov 29;126(1-2):159-74
pubmed: 11704261
Nature. 2007 May 24;447(7143):396-8
pubmed: 17522671
Bioinformatics. 2011 Jun 1;27(11):1571-2
pubmed: 21493656
PLoS Biol. 2018 Oct 16;16(10):e2006497
pubmed: 30325916
Nat Rev Genet. 2012 May 29;13(7):484-92
pubmed: 22641018
Neurobiol Learn Mem. 2018 Jul;152:71-79
pubmed: 29783059
Schizophr Res. 2016 Mar;171(1-3):1-15
pubmed: 26803692
Handb Exp Pharmacol. 2009;(192):29-60
pubmed: 19184645
Nat Neurosci. 2013 Jan;16(1):42-7
pubmed: 23242310
Nicotine Tob Res. 2011 Jan;13(1):41-6
pubmed: 21097981
Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S186-95
pubmed: 19560279